AN SIRNA-BASED MICROBICIDE TO PREVENT HIV TRANSMISSION

$61,801P51FY2010RRNIH

Tulane University Of Louisiana, New Orleans LA

Investigators

Linked publications & trials

Paper 38091409 Paper 36890518 Paper 36678479 Paper 36096938 Paper 35333631 Paper 35281029 Paper 35148813 Paper 34954656 Paper 33771926 Paper 31431806 Paper 31398085 Paper 31119711 Paper 31114576 Paper 30830861 Paper 30617987 Paper 30404798 Paper 30260764 Paper 30040479 Paper 29514950 Paper 29504290 Paper 29437924 Paper 29408631 Paper 29343566 Paper 29132995 Paper 28558791 Paper 28381571 Paper 28153013 Paper 27834864 Paper 27792681 Paper 27605560 Paper 27552154 Paper 27466784 Paper 27430034 Paper 27391120 Paper 27273075 Paper 26937033 Paper 26851132 Paper 26796229 Paper 26790502 Paper 26714480 Paper 26700298 Paper 26699868 Paper 26647718 Paper 26607731 Paper 26588868 Paper 26539878 Paper 26432896 Paper 26419894 Paper 26365904 Paper 26336283 Paper 26242703 Paper 26178993 Paper 26052540 Paper 25960611 Paper 25956030 Paper 25943275 Paper 25892509 Paper 25889406 Paper 25730547 Paper 25639184 Paper 25635151 Paper 25591175 Paper 25452565 Paper 25378491 Paper 25360552 Paper 25322074 Paper 25257285 Paper 25232870 Paper 25197327 Paper 25165491 Paper 25165117 Paper 25164280 Paper 25143472 Paper 25138734 Paper 25092823 Paper 25055842 Paper 25024382 Paper 25024365 Paper 24981450 Paper 24970236 Paper 24962586 Paper 24956211 Paper 24758934 Paper 24743303 Paper 24740100 Paper 24549971 Paper 24534529 Paper 24524407 Paper 24517274 Paper 24490123 Paper 24464410 Paper 24272803 Paper 24266615 Paper 24157855 Paper 24117013 Paper 24114360 Paper 24109219 Paper 24105901 Paper 24047412 Paper 24045890

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This program project is a collaborative study with Dr. Lieberman (Harvard) to develop an effective microbicide based on small interfering RNA (siRNA) technology. We are also developing a model of herpesvirus transmission to determine if this can also be used to develop preventative microbicides. Since genital herpes is associated with markedly increased rates of HIV transmission, and since genital herpes infects over 20% of adolescents/adults, this approach is also in line with our goals to reduce HIV transmission. We have now generated a large scale HSV-2 stock for use in NHP challenge experiments which will begin in February. We will also start testing siRNAs against CD45 and nectin to reduce inflammation and mask HSV-2 receptors respectively in vivo.

View original record on NIH RePORTER →